Skip to main content

The Wistar Institute

|

Pancreatic Cancer Survivor and Pancreatic Cancer Advocate Meet Wistar Scientist Focused on Research Advances

Wistar’s Dr. Rahul Shinde with PanCAN’s Nick Pifani and Bruce Platt Rally Around Common Bond Meet Nick Pifani who came to Wistar to share his story of surviving pancreatic cancer; he was one of several in his family who faced pancreatic cancer and w…
Read more
|

Award-Winning Biotech Training Program to Begin Recruitment with New Employer Partner in Life Sciences

PHILADELPHIA (January 17, 2024) – The West Philadelphia Skills Initiative and The Wistar Institute are collaborating once again with support from the Philadelphia Industrial Development Corporation and the Chamber of Commerce for Greater Philadelphi…
Read more
|

Teaching Students How to Create Vaccines: Inside Dr. David Weiner’s Vaccines and Immune Therapeutics Class

Since 1997, Wistar’s Dr. David Weiner has taught Vaccines and Immune Therapeutics for the University of Pennsylvania’s Perelman School of Medicine. After joining The Wistar Institute — where he serves as the Executive Vice President, W.W. Smith Char…
Read more
|

The Wistar Institute Announces the Appointment of Aleister Saunders, Ph.D., and Patrick Oates, Ph.D., to its Board of Trustees

PHILADELPHIA—(Dec. 18, 2023)—The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Aleister Saunders, Ph.D., and Patrick Oates, Ph.D., to its Board of Trustees. The two new t…
Read more
|

The Wistar Institute Recruits Dr. Filippo Veglia to the Ellen and Ronald Caplan Cancer Center

PHILADELPHIA—(Dec. 13, 2023)— The Wistar Institute, an international biomedical research leader in cancer, infectious disease, immunology, and vaccine development, is pleased to announce the recruitment of Filippo Veglia, Ph.D., to the Ellen and Ron…
Read more
|

Wistar Scientists Enhance Cell-Based Therapy to Destroy Solid Tumors

PHILADELPHIA—(Dec. 13, 2023)—Wistar researchers successfully tested a simple intervention that could unlock greater anti-tumor power in therapies that use T cells — an approach known as “cell-based therapy,” which uses specially designed T cells to…
Read more
|

Filippo Veglia, Ph.D.

Assistant Professor, Genome Regulation and Cell Signaling Program, Ellen and Ronald Caplan Cancer Center
Read more
|

For Wistar researcher Dr. Gundi Ertl, time away from the lab is best spent with furry — and feathered — friends.  

Managing a lab involves a complex orchestration of tasks: running experiments, writing grants, engaging staff, managing the research budget, and answering emails. With many tasks to juggle, you wouldn’t be wrong to think that when the day ends or th…
Read more
|

How the Wistar Flow Cytometry Facility Came to Be

Jeffrey Faust keeps a toolbox next to his office. It looks like something you might find in a garage: screwdrivers, Allen wrenches (standard & metric), wire caps, the indispensable duct tape, and so on. But Jeffrey doesn’t tinker with cars or ha…
Read more
|

Wistar Scientists Identify Esophageal Cancer Biomarkers

PHILADELPHIA—(Dec. 5, 2023)—Wistar scientists have developed a new tool that can help identify cancer-associated microbes by using machine learning technology. Under the leadership of Dr. Noam Auslander — assistant professor in the Ellen and Ronald…
Read more